Literature DB >> 36012553

Targeted Modification of Mammalian DNA by a Novel Type V Cas12a Endonuclease from Ruminococcus bromii.

Ruslan Vasilev1,2, Natalia Gunitseva1, Regina Shebanova3, Aleksei Korzhenkov1, Anna Vlaskina1, Marta Evteeva1, Irina Polushkina1, Natalia Nikitchina3,4, Stepan Toshchakov1, Piotr Kamenski2, Maxim Patrushev1, Ilya Mazunin3,5.   

Abstract

Type V Cas12a nucleases are DNA editors working in a wide temperature range and using expanded protospacer-adjacent motifs (PAMs). Though they are widely used, there is still a demand for discovering new ones. Here, we demonstrate a novel ortholog from Ruminococcus bromii sp. entitled RbCas12a, which is able to efficiently cleave target DNA templates, using the particularly high accessibility of PAM 5'-YYN and a relatively wide temperature range from 20 °C to 42 °C. In comparison to Acidaminococcus sp. (AsCas12a) nuclease, RbCas12a is capable of processing DNA more efficiently, and can be active upon being charged by spacer-only RNA at lower concentrations in vitro. We show that the human-optimized RbCas12a nuclease is also active in mammalian cells, and can be applied for efficient deletion incorporation into the human genome. Given the advantageous properties of RbCas12a, this enzyme shows potential for clinical and biotechnological applications within the field of genome editing.

Entities:  

Keywords:  CRISPR; Cas endonuclease; genome editing; mammalian cells; site-directed mutagenesis

Mesh:

Substances:

Year:  2022        PMID: 36012553      PMCID: PMC9409102          DOI: 10.3390/ijms23169289

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   6.208


  30 in total

1.  Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.

Authors:  Bernd Zetsche; Jonathan S Gootenberg; Omar O Abudayyeh; Ian M Slaymaker; Kira S Makarova; Patrick Essletzbichler; Sara E Volz; Julia Joung; John van der Oost; Aviv Regev; Eugene V Koonin; Feng Zhang
Journal:  Cell       Date:  2015-09-25       Impact factor: 41.582

Review 2.  CRISPR-Cas: Adapting to change.

Authors:  Simon A Jackson; Rebecca E McKenzie; Robert D Fagerlund; Sebastian N Kieper; Peter C Fineran; Stan J J Brouns
Journal:  Science       Date:  2017-04-06       Impact factor: 47.728

3.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

4.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

5.  Engineered Cpf1 variants with altered PAM specificities.

Authors:  Linyi Gao; David B T Cox; Winston X Yan; John C Manteiga; Martin W Schneider; Takashi Yamano; Hiroshi Nishimasu; Osamu Nureki; Nicola Crosetto; Feng Zhang
Journal:  Nat Biotechnol       Date:  2017-06-05       Impact factor: 54.908

6.  Repurposing CRISPR-Cas12b for mammalian genome engineering.

Authors:  Fei Teng; Tongtong Cui; Guihai Feng; Lu Guo; Kai Xu; Qingqin Gao; Tianda Li; Jing Li; Qi Zhou; Wei Li
Journal:  Cell Discov       Date:  2018-11-27       Impact factor: 10.849

7.  Mb- and FnCpf1 nucleases are active in mammalian cells: activities and PAM preferences of four wild-type Cpf1 nucleases and of their altered PAM specificity variants.

Authors:  Eszter Tóth; Bernadett C Czene; Péter I Kulcsár; Sarah L Krausz; András Tálas; Antal Nyeste; Éva Varga; Krisztina Huszár; Nóra Weinhardt; Zoltán Ligeti; Adrienn É Borsy; Elfrieda Fodor; Ervin Welker
Journal:  Nucleic Acids Res       Date:  2018-11-02       Impact factor: 16.971

8.  Parallelization of MAFFT for large-scale multiple sequence alignments.

Authors:  Tsukasa Nakamura; Kazunori D Yamada; Kentaro Tomii; Kazutaka Katoh
Journal:  Bioinformatics       Date:  2018-07-15       Impact factor: 6.937

9.  Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing.

Authors:  Alexander A Sousa; Russell T Walton; Benjamin P Kleinstiver; Y Esther Tak; Jonathan Y Hsu; Kendell Clement; Moira M Welch; Joy E Horng; Jose Malagon-Lopez; Irene Scarfò; Marcela V Maus; Luca Pinello; Martin J Aryee; J Keith Joung
Journal:  Nat Biotechnol       Date:  2019-02-11       Impact factor: 68.164

10.  CRISPR-Cas12a Possesses Unconventional DNase Activity that Can Be Inactivated by Synthetic Oligonucleotides.

Authors:  Bin Li; Jingyue Yan; Youxi Zhang; Wenqing Li; Chunxi Zeng; Weiyu Zhao; Xucheng Hou; Chengxiang Zhang; Yizhou Dong
Journal:  Mol Ther Nucleic Acids       Date:  2020-01-14       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.